Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-08-16

Clinical Trial Update: Study of Hydroxyurea to Treat Sickle Cell Disease

View source ↗

Summary

A clinical trial evaluating hydroxyurea for sickle cell disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HYDROXYUREA (Hydroxyurea)

Snippet

Sponsor: Mersin University | Conditions: Sickle Cell Disease | Status: COMPLETED